Published in J Allergy Clin Immunol on October 20, 2010
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04
Immunotherapy in allergy and cellular tests: state of art. Hum Vaccin Immunother (2014) 0.98
Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.93
Allergen immunotherapy and allergic rhinitis: false beliefs. BMC Med (2013) 0.92
Detection of Allergen Specific Antibodies From Nasal Secretion of Allergic Rhinitis Patients. Allergy Asthma Immunol Res (2016) 0.92
Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses. Chest (2012) 0.88
Sublingual delivery of vaccines for the induction of mucosal immunity. Immune Netw (2013) 0.88
Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation. Immunology (2013) 0.86
Effector and central memory T helper 2 cells respond differently to peptide immunotherapy. Proc Natl Acad Sci U S A (2014) 0.84
Subtropical grass pollen allergens are important for allergic respiratory diseases in subtropical regions. Clin Transl Allergy (2012) 0.83
Reduced in vitro T-cell responses induced by glutaraldehyde-modified allergen extracts are caused mainly by retarded internalization of dendritic cells. Immunology (2012) 0.82
New routes for allergen immunotherapy. Hum Vaccin Immunother (2012) 0.81
Sublingual immunotherapy in allergic rhinitis: efficacy, safety, adherence and guidelines. Clin Exp Otorhinolaryngol (2014) 0.80
5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study. J Asthma Allergy (2013) 0.79
Allergen-specific IgG antibodies purified from mite-allergic patients sera block the IgE recognition of Dermatophagoides pteronyssinus antigens: an in vitro study. Clin Dev Immunol (2013) 0.79
Preventive capacity of allergen immunotherapy on the natural history of allergy. J Prev Med Hyg (2013) 0.78
Effects of rhinophototherapy on quality of life in persistant allergic rhinitis. Clin Exp Otorhinolaryngol (2013) 0.78
Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study. Biomed Res Int (2015) 0.78
Chemokines mediate ethanol-induced exacerbations of murine cockroach allergen asthma. Clin Exp Immunol (2013) 0.77
An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodology. Clin Transl Allergy (2014) 0.76
Diseases of the nose and paranasal sinuses in child. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.76
Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ. Clin Exp Immunol (2014) 0.76
Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids - differences in vivo and in vitro. Clin Exp Immunol (2014) 0.76
Allergen immunotherapy: routes, safety, efficacy, and mode of action. Immunotargets Ther (2013) 0.75
Allergen immunotherapy in asthma; what is new? Asthma Res Pract (2015) 0.75
Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report. Ital J Pediatr (2017) 0.75
The relationship between autoimmunity and specific immunotherapy for allergic diseases. Hum Vaccin Immunother (2015) 0.75
Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract. Curr Allergy Asthma Rep (2017) 0.75
Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children. Front Pediatr (2017) 0.75
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol (2010) 5.80
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med (2011) 5.61
The Norway spruce genome sequence and conifer genome evolution. Nature (2013) 4.74
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest (2009) 4.10
Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med (2008) 3.90
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med (2005) 3.48
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Scanning the genome for gene single nucleotide polymorphisms involved in adaptive population differentiation in white spruce. Mol Ecol (2008) 2.91
Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ (2002) 2.81
Rhinitis and onset of asthma: a longitudinal population-based study. Lancet (2008) 2.68
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56
The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol (1985) (2006) 2.40
Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol (2004) 2.40
Long-acting β2-agonist step-off in patients with controlled asthma. Arch Intern Med (2012) 2.24
Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol (2010) 2.19
Assembling the 20 Gb white spruce (Picea glauca) genome from whole-genome shotgun sequencing data. Bioinformatics (2013) 2.18
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med (2010) 2.15
Methylene blue-treated plasma: an increased allergy risk? J Allergy Clin Immunol (2012) 2.11
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol (2005) 2.11
Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis. Lancet (2005) 2.07
Omalizumab-induced reductions in mast cell Fce psilon RI expression and function. J Allergy Clin Immunol (2004) 2.06
Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg (2004) 2.01
Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol (2003) 2.01
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol (2013) 1.96
Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol (2003) 1.94
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.87
Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol (2007) 1.85
Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol (2003) 1.82
Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol (2005) 1.78
Phenotypic determinants of uncontrolled asthma. J Allergy Clin Immunol (2009) 1.73
Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med (2004) 1.69
Is occupational asthma to diisocyanates a non-IgE-mediated disease? J Allergy Clin Immunol (2006) 1.68
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med (2008) 1.64
Tregs and allergic disease. J Clin Invest (2004) 1.64
Bronchodilatory effect of deep inspiration is absent in subjects with mild COPD. Chest (2004) 1.62
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol (2011) 1.62
Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently. J Mol Med (Berl) (2001) 1.60
Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. J Allergy Clin Immunol (2004) 1.59
Enhancing genetic mapping of complex genomes through the design of highly-multiplexed SNP arrays: application to the large and unsequenced genomes of white spruce and black spruce. BMC Genomics (2008) 1.57
Generation, annotation, analysis and database integration of 16,500 white spruce EST clusters. BMC Genomics (2005) 1.54
A white spruce gene catalog for conifer genome analyses. Plant Physiol (2011) 1.54
Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol (2004) 1.53
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol (2007) 1.53
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J (2013) 1.51
Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol (2004) 1.47
Mechanisms of immunotherapy. J Allergy Clin Immunol (2004) 1.45
Primum non nocere. Prim Care Respir J (2005) 1.44
Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol (2008) 1.43
Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort. Am J Respir Crit Care Med (2010) 1.43
Effects of exercise training on airway responsiveness and airway cells in healthy subjects. J Appl Physiol (1985) (2010) 1.43
Automated SNP detection from a large collection of white spruce expressed sequences: contributing factors and approaches for the categorization of SNPs. BMC Genomics (2006) 1.41
Clinical and biological heterogeneity in children with moderate asthma. Am J Respir Crit Care Med (2003) 1.39
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol (2008) 1.38
Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol (2006) 1.33
A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet (2006) 1.33
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol (2013) 1.33
Association genetics of wood physical traits in the conifer white spruce and relationships with gene expression. Genetics (2011) 1.30
Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol (2005) 1.30
Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol (2012) 1.29
Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol (2012) 1.29
Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol (2012) 1.28
Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness. Curr Allergy Asthma Rep (2011) 1.28
Scanning the genome for gene SNPs related to climate adaptation and estimating selection at the molecular level in boreal black spruce. Mol Ecol (2011) 1.28
Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol (2007) 1.28
State of world allergy report 2008: allergy and chronic respiratory diseases. World Allergy Organ J (2008) 1.27
Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol (2004) 1.26
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.26
A spruce gene map infers ancient plant genome reshuffling and subsequent slow evolution in the gymnosperm lineage leading to extant conifers. BMC Biol (2012) 1.26
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol (2006) 1.26
Variation in mitochondrial DNA reveals multiple distant glacial refugia in black spruce (Picea mariana), a transcontinental North American conifer. Mol Ecol (2004) 1.25
The role of vitamin D in asthma. Ann Allergy Asthma Immunol (2010) 1.25
Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med (2006) 1.23
Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med (2003) 1.23
Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol (2005) 1.23
Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses. J Allergy Clin Immunol (2009) 1.23
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol (2007) 1.22
Cultured lung fibroblasts from ovalbumin-challenged "asthmatic" mice differ functionally from normal. Am J Respir Cell Mol Biol (2007) 1.22
Asthma outcomes workshop: overview. J Allergy Clin Immunol (2012) 1.22
Decoupled mitochondrial and chloroplast DNA population structure reveals Holocene collapse and population isolation in a threatened Mexican-endemic conifer. Mol Ecol (2006) 1.20
Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population. J Allergy Clin Immunol (2005) 1.20
QTL mapping in white spruce: gene maps and genomic regions underlying adaptive traits across pedigrees, years and environments. BMC Genomics (2011) 1.20
Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008. World Allergy Organ J (2012) 1.19